Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001707451-17-000003
Filing Date
2017-08-21
Accepted
2017-08-21 15:14:43
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1 axium_s1.htm S-1 522386
2 ARTICLES OF INCORPORATION axium_ex0301.htm EX-3.1 340543
3 BYLAWS axium_ex0302.htm EX-3.2 91565
4 OPINION axium_ex0501.htm EX-5.1 9411
5 CONSENT axium_ex2302.htm EX-23.2 3170
6 GRAPHIC image_001.jpg GRAPHIC 4655
7 GRAPHIC image_002.jpg GRAPHIC 2231
8 PATENT APPLICATION axium_ex9901.htm EX-99.1 72273
9 GRAPHIC image_003.jpg GRAPHIC 17744
10 GRAPHIC image_004.jpg GRAPHIC 3082
  Complete submission text file 0001707451-17-000003.txt   1078930
Mailing Address 265 EASTCHESTER DR. SUITE 133, #201 HIGHPOINT NC 27262
Business Address 265 EASTCHESTER DR. SUITE 133, #201 HIGHPOINT NC 27262 888-805-7734
Axium Pharmaceuticals Inc. (Filer) CIK: 0001715028 (see all company filings)

EIN.: 821984738 | State of Incorp.: NC | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-220076 | Film No.: 171043010